Home
Concord Biotech Ltd EPS
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fconcord-biotech-ltd.png&w=128&q=75)
Concord Biotech Ltd
NSE: CONCORDBIO
EPS
Key Highlights
- The Earning per Share of Concord Biotech Ltd is ₹ 31.19 as of 18 Feb 25 .
- The earning per share of Concord Biotech Ltd changed from ₹ 5.21 to ₹ 7.26 over 7 quarters. This represents a CAGR of 20.88% .
Historical Earning per Share of Concord Biotech Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Concord Biotech Ltd
Company Fundamentals for Concord Biotech Ltd
Market Cap
18,450 Cr
EPS
31.2
P/E Ratio (TTM)
56.5
P/B Ratio (TTM)
11.6
Day’s High
1750.05
Day’s Low
1683.7
DTE
0.0
ROE
20.6
52 Week High
2658.0
52 Week Low
1326.9
ROCE
27.8
Market Price of Concord Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
18 Feb 2025 | 1763.6 |
17 Feb 2025 | 1684 |
14 Feb 2025 | 1693.2 |
13 Feb 2025 | 2109.95 |
12 Feb 2025 | 2120.75 |
11 Feb 2025 | 2144.55 |
10 Feb 2025 | 2235.25 |
07 Feb 2025 | 2342.25 |
06 Feb 2025 | 2343.65 |
05 Feb 2025 | 2270.6 |
SWOT Analysis Of Concord Biotech Ltd
BlinkX Score for Concord Biotech Ltd
Asset Value vs Market Value of Concord Biotech Ltd
Market Value
₹ 18,450
Asset Value
Value addition
27.2 X
₹ 655
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Concord Biotech Ltd | 18450 | 31.19 |
Sun Pharmaceuticals Industries Ltd | 408259 | 49.16 |
Divis Laboratories Ltd | 154917 | 77.86 |
Cipla Ltd | 119705 | 61.78 |
Torrent Pharmaceuticals Ltd | 103096 | 55.02 |
Dr Reddys Laboratories Ltd | 99951 | 64.37 |
Company | |
---|---|
Concord Biotech Ltd | 18450 |
Sun Pharmaceuticals Industries Ltd | 408259 |
Divis Laboratories Ltd | 154917 |
Cipla Ltd | 119705 |
Torrent Pharmaceuticals Ltd | 103096 |
Dr Reddys Laboratories Ltd | 99951 |
Historical Market Cap of Concord Biotech Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Concord Biotech Ltd
Historical Revenue of Concord Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Concord Biotech Ltd
Historical EBITDA of Concord Biotech Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Concord Biotech Ltd
Historical Net Profit of Concord Biotech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Concord Biotech Ltd
Dividend Payout Over Time
Concord Biotech Ltd News Hub
Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter
Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against
Read more
09 Aug 24
Volumes jump at Concord Biotech Ltd counter
K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst
Read more
29 Aug 24
Concord Biotech to conduct board meeting
Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow
Read more
06 Nov 24
Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter
Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as a
Read more
11 Nov 24
Document
Concalls